| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
nuclear factor kappa B subunit 1 | 0.396 | 0.923 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 7 | 0 | 2003 | 2018 | ||||||||
|
fms related receptor tyrosine kinase 4 | 0.457 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 0.970 | 4 | 0 | 2000 | 2019 | ||||||||
|
L1 cell adhesion molecule | 0.475 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 0.966 | 2 | 0 | 2005 | 2020 | ||||||||
|
ret proto-oncogene | 0.392 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 0.940 | 2 | 0 | 1992 | 2020 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
phenotype | 0.400 | None | 0.996 | 2 | 0 | 2001 | 2020 | ||||||||
|
tight junction protein 1 | 0.576 | 0.692 | 1.00 |
|
phenotype | 0.060 | None | 1.000 | 2 | 0 | 2003 | 2019 | ||||||||
|
ADAM metallopeptidase domain 10 | 0.489 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 0.955 | 1 | 0 | 2007 | 2019 | ||||||||
|
versican | 0.497 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 0 | 1996 | 2019 | ||||||||
|
jagged canonical Notch ligand 1 | 0.429 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 0 | 2004 | 2019 | ||||||||
|
EPH receptor A4 | 0.566 | 0.846 | 1.00 |
|
phenotype | 0.020 | None | 1.000 | 1 | 0 | 2008 | 2017 | ||||||||
|
enhancer of zeste 2 polycomb repressive complex 2 subunit | 0.376 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 0.982 | 1 | 0 | 2005 | 2019 | ||||||||
|
Rho GTPase activating protein 35 | 0.751 | 0.269 | 1.00 |
|
phenotype | 0.030 | None | 1.000 | 1 | 0 | 2008 | 2016 | ||||||||
|
LDL receptor related protein 1 | 0.482 | 0.769 | 1.00 |
|
phenotype | 0.090 | None | 1.000 | 1 | 0 | 2007 | 2019 | ||||||||
|
notch receptor 1 | 0.369 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 0 | 2001 | 2019 | ||||||||
|
ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 | 0.556 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 0 | 2000 | 2019 | ||||||||
|
platelet derived growth factor receptor alpha | 0.415 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 0.914 | 1 | 0 | 2001 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
phenotype | 0.400 | None | 0.976 | 1 | 0 | 2003 | 2020 | ||||||||
|
polycystin 1, transient receptor potential channel interacting | 0.493 | 0.769 | 1.00 |
|
phenotype | 0.050 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
protein kinase, DNA-activated, catalytic subunit | 0.540 | 0.808 | 1.00 |
|
phenotype | 0.050 | None | 1.000 | 1 | 0 | 2007 | 2017 | ||||||||
|
AT-rich interaction domain 4A | 0.769 | 0.192 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
Rho associated coiled-coil containing protein kinase 1 | 0.513 | 0.731 | 1.00 |
|
phenotype | 0.100 | None | 0.968 | 1 | 0 | 2002 | 2020 | ||||||||
|
metastasis associated 1 | 0.547 | 0.692 | 1.00 |
|
phenotype | 0.100 | None | 0.949 | 1 | 0 | 1994 | 2019 | ||||||||
|
slit guidance ligand 2 | 0.511 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 0.909 | 1 | 0 | 2007 | 2019 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
phenotype | 0.400 | None | 0.962 | 6 | 0 | 1996 | 2020 | ||||||||
|
insulin like growth factor 2 mRNA binding protein 3 | 0.570 | 0.577 | 1.00 |
|
phenotype | 0.050 | None | 1.000 | 1 | 0 | 2008 | 2018 |